Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+869K
-
Total reported value, excl. options
-
$323M
-
Value change
-
+$20.9M
-
Put/Call ratio
-
2.52
-
Number of buys
-
39
-
Number of sells
-
-34
-
Price
-
$24.23
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2014
88 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2014.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 386M outstanding shares and own 3.45% of the company stock.
Largest 10 shareholders include FMR LLC (1.88M shares), HEARTLAND ADVISORS INC (1.22M shares), ACK Asset Management LLC (685K shares), BLAIR WILLIAM & CO/IL (645K shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (631K shares), Lyon Street Capital, LLC (560K shares), Park West Asset Management LLC (483K shares), Whitebox Advisors LLC (454K shares), RENAISSANCE TECHNOLOGIES LLC (450K shares), and Cortina Asset Management, LLC (432K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.